164 related articles for article (PubMed ID: 35653037)
21. Opportunities for 2-[(18)F] fluoro-2-deoxy-D-glucose PET/CT in cervical-vaginal neuroendocrine carcinoma: case series and literature review.
Lin Y; Lin WY; Liang JA; Lu YY; Wang HY; Tsai SC; Kao CH
Korean J Radiol; 2012; 13(6):760-70. PubMed ID: 23118575
[TBL] [Abstract][Full Text] [Related]
22. To evaluate the treatment response of locally advanced esophageal cancer after preoperative chemoradiotherapy by FDG-PET/CT scan.
Huang JW; Yeh HL; Hsu CP; Lu YY; Chuang CY; Lin JC; Lin JF; Chang CF
J Chin Med Assoc; 2015 Apr; 78(4):229-34. PubMed ID: 25557468
[TBL] [Abstract][Full Text] [Related]
23. Curative resection of combined neuroendocrine carcinoma and adenocarcinoma of the gallbladder.
Kim DI; Seo HI; Lee JY; Kim HS; Han KT
Tumori; 2011; 97(6):815-8. PubMed ID: 22322853
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.
Honma Y; Nagashima K; Hirano H; Shoji H; Iwasa S; Takashima A; Okita N; Kato K; Boku N; Murakami N; Inaba K; Ito Y; Itami J; Kanamori J; Oguma J; Daiko H
Cancer Med; 2020 Jan; 9(2):595-604. PubMed ID: 31794158
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine tumor of the gallbladder.
Elahi F; Ahmadzadeh A; Yadollahzadeh M; Hassanpour K; Babaei M
Arch Iran Med; 2013 Feb; 16(2):123-5. PubMed ID: 23360636
[TBL] [Abstract][Full Text] [Related]
26. Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol.
Bongiovanni A; Liverani C; Pusceddu S; Leo S; Di Meglio G; Tamberi S; Santini D; Gelsomino F; Pucci F; Berardi R; Lolli I; Bergamo F; Ricci S; Foca F; Severi S; Ibrahim T;
BMJ Open; 2020 Jul; 10(7):e034393. PubMed ID: 32690499
[TBL] [Abstract][Full Text] [Related]
27. Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report.
Semrau S; Agaimy A; Pavel M; Lubgan D; Schmidt D; Cavallaro A; Golcher H; Grützmann R; Fietkau R
J Med Case Rep; 2019 Mar; 13(1):82. PubMed ID: 30902067
[TBL] [Abstract][Full Text] [Related]
28. Update in clinical management for gallbladder neuroendocrine carcinoma.
Chu H; Shi Y; Liu J; Huang D; Zhang J; Dou C
Medicine (Baltimore); 2021 Apr; 100(14):e25449. PubMed ID: 33832150
[TBL] [Abstract][Full Text] [Related]
29. [Long-Term Survival after Surgical Resection for Small Cell Neuroendocrine Carcinoma of the Gallbladder].
Yazawa K; Takeda K; Sawada Y; Watanabe J; Sato T; Yamaguchi T; Sekikawa Z; Tanabe M; Kunisaki C; Endo I
Gan To Kagaku Ryoho; 2022 Apr; 49(4):473-477. PubMed ID: 35444140
[TBL] [Abstract][Full Text] [Related]
30. [Gallbladder Cancer with Multiple Liver Metastases Completely Responding to Gemcitabile plus Cisplatin Chemotherapy-A Case Report].
Jin H; Ichisawa A; Hagiwara Y; Hara Y; Kimura T; Yonaiyama S; Yoshikawa T; Nakai M; Tokura T; Aoki K; Kawashima H; Toyoki Y; Endo M
Gan To Kagaku Ryoho; 2020 Feb; 47(2):364-366. PubMed ID: 32381990
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy.
Song W; Chen W; Zhang S; Peng J; He Y
Diagn Pathol; 2012 Nov; 7():163. PubMed ID: 23186166
[TBL] [Abstract][Full Text] [Related]
32. Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival.
Everitt S; Ball D; Hicks RJ; Callahan J; Plumridge N; Trinh J; Herschtal A; Kron T; Mac Manus M
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):947-955. PubMed ID: 29063854
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
[TBL] [Abstract][Full Text] [Related]
34. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
35. Conversion surgery after extensive chemotherapy for stage IV mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: clinical implications from the patterns of response and recurrence.
Kamei K; Shindoh J; Kiya Y; Matsumoto I; Hashimoto M; Takeyama Y
Clin J Gastroenterol; 2020 Apr; 13(2):240-246. PubMed ID: 31617127
[TBL] [Abstract][Full Text] [Related]
36. Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.
Bruera G; Giuliani A; Romano L; Chiominto A; Di Sibio A; Mastropietro S; Cosenza P; Ricevuto E; Schietroma M; Carlei F;
BMC Cancer; 2019 Oct; 19(1):960. PubMed ID: 31619203
[TBL] [Abstract][Full Text] [Related]
37. The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer.
Kim KR; Shim HJ; Hwang JE; Cho SH; Chung IJ; Park KS; Kang SR; Kwon SY; Chung WK; Bae WK
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):170-178. PubMed ID: 28940101
[TBL] [Abstract][Full Text] [Related]
38. Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial.
Kong FM; Ten Haken RK; Schipper M; Frey KA; Hayman J; Gross M; Ramnath N; Hassan KA; Matuszak M; Ritter T; Bi N; Wang W; Orringer M; Cease KB; Lawrence TS; Kalemkerian GP
JAMA Oncol; 2017 Oct; 3(10):1358-1365. PubMed ID: 28570742
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Gallbladder Cancers: A New Paradigm.
Engineer R; Goel M; Chopra S; Patil P; Purandare N; Rangarajan V; Ph R; Bal M; Shrikhande S; Shrivastava SK; Mehta S
Ann Surg Oncol; 2016 Sep; 23(9):3009-15. PubMed ID: 27075323
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Value of
Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
